Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
16.70
+0.13 (+0.78%)
Streaming Delayed Price
Updated: 3:07 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Adma Biologics
< Previous
1
2
3
4
5
6
Next >
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
December 07, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Proposed Public Offering of Common Stock
December 06, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate
December 06, 2022
Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Recap: ADMA Biologics Q2 Earnings
August 10, 2022
ADMA Biologics (NASDAQ:ADMA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
November 11, 2022
Gainers
Via
Benzinga
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session
November 10, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...
Via
Benzinga
Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
November 10, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 10, 2022
Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million.
Via
Benzinga
Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 10, 2022
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update
November 09, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
A Preview Of ADMA Biologics's Earnings
November 08, 2022
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that ADMA...
Via
Benzinga
ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022
November 02, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
October 31, 2022
From
ADMA Biologics, Inc.
Via
GlobeNewswire
7 A-Rated Stocks to Buy for Less Than $10
September 23, 2022
While stocks under $10 don't carry the cache of blue-chip stocks, the returns that they offer can be enticing.
Via
InvestorPlace
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
October 13, 2022
Upgrades
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 02, 2022
Via
Benzinga
Stocks That Made New Highs On Friday, Aug. 19
August 21, 2022
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.
Via
Talk Markets
ADMA Biologics: Earnings Outlook
August 09, 2022
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that ADMA...
Via
Benzinga
Why ADMA Biologics Shares Are Rising Today
June 27, 2022
ADMA Biologics Inc (NASDAQ: ADMA) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration approval for its sixth plasma collection center.
Via
Benzinga
Looking Into ADMA Biologics's Return On Capital Employed
June 16, 2022
Benzinga Pro data, ADMA Biologics (NASDAQ:ADMA) reported Q1 sales of $29.10 million. Earnings fell to a loss of $25.01 million, resulting in a 50.2% decrease from last quarter.
Via
Benzinga
Recap: ADMA Biologics Q1 Earnings
May 11, 2022
ADMA Biologics (NASDAQ:ADMA) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ADMA Biologics missed estimated...
Via
Benzinga
Earnings Outlook For ADMA Biologics
May 10, 2022
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that ADMA...
Via
Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
May 09, 2022
Biotech stocks declined yet again in the week ending May 6, dragged lower by macroeconomic concerns following the Federal Reserve's 50-basis-point rate hike. The iShares Biotechnology ETF (NASDAQ:...
Via
Benzinga
ADMA Biologics's Return On Capital Employed Overview
March 25, 2022
According to data from Benzinga Pro, during Q4, ADMA Biologics's (NASDAQ:ADMA) reported sales totaled $26.38 million. Despite a 6.0% increase in earnings, the company posted a...
Via
Benzinga
ADMA Biologics' Q4 Top-Line Surpass Estimates, Concludes $175M Debt Refinancing
March 25, 2022
ADMA Biologics Inc (NASDAQ: ADMA) closed a debt refinancing with Hayfin Capital Management of $150 million, and up to an additional $25 million tied to specific revenue...
Via
Benzinga
Earnings Scheduled For March 24, 2022
March 24, 2022
Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...
Via
Benzinga
ADMA Biologics's Earnings Outlook
March 23, 2022
ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
ADMA Biologics Shares Gain As Interim Q4 Sales Beat Expectation
January 19, 2022
ADMA Biologics Inc (NASDAQ: ADMA) expects Q4 Sales of approximately $26 million, compared to $14 million a year ago and better than the consensus of $21.76 million....
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.